Time spent in hospital after liver transplantation: Effects of primary liver disease and comorbidity

Table 1 Demographic characteristics of the adult recipients of a first liver transplant in England who survived the first two years after transplantation

Characteristic	Value	Missing (n)
Number	3772
Age (yr)	52 (42-59)	0
Sex (%)		0
Male	2214 (58.7)
Female	1558 (41.3)
Primary liver disease (%)		0
Cancer	525 (13.9)
Acute hepatic failure	455 (12.1)
Hepatitis C cirrhosis	392 (10.4)
Primary sclerosing cholangitis	354 (9.4)
Hepatitis B cirrhosis	98 (2.6)
Primary biliary cirrhosis	507 (13.4)
Alcoholic cirrhosis	753 (20.0)
Autoimmune and cryptogenic cirrhosis	348 (9.2)
Metabolic liver disease	107 (2.8)
Other liver disease	233 (6.2)
Comorbidities (%)
Cardiovascular disease	200 (5.3)	0
Congestive cardiac failure	82 (2.2)	0
Connective tissue disease	134 (3.6)	0
Dementia	159 (4.2)	0
Diabetes mellitus	784 (20.8)	0
Non-hepatic malignancy	40 (1.1)	0
Chronic pulmonary disease	344 (9.1)	0
Chronic renal disease	247 (6.6)	0
Era of liver transplantation (%)		0
April 1997 - September 2000	841 (22.3)
October 2000 - September 2003	899 (23.8)
October 2003 - September 2006	897 (23.8)
October 2006 - March 2010	1135 (30.1)
Bilirubin (µmol/L)	54 (27-124)	20
Creatinine (µmol/L)	89 (74-109)	2
INR	1.4 (1.2-1.8)	162
Sodium (mmol/L)	137 (134-140)	8
UKELD score	55 (51-59)	184

Results are numbers (percentages) or medians (interquartile ranges). INR: International normalised ratio; UKELD: United Kingdom End-stage Liver Disease.